AptarGroup (ATR) Q2 Revenue Rises 6%
AptarGroup (NYSE:ATR), a global leader in dosing, dispensing, and protection technologies for the pharmaceutical, beauty, and food and beverage markets, reported its earnings results for the second quarter of fiscal 2025 on July 31, 2025. The company delivered adjusted earnings per share of $1.66, outpacing analyst estimates of $1.59 (non-GAAP). GAAP revenue was $966 million, above the $954.93 million consensus forecast (GAAP). The period was marked by margin improvement, positive sales growth in key Pharma and Closures segments, and disciplined cost management. Overall, the period reflected resilient demand in essential end markets, despite some unevenness in other business lines and persistent macroeconomic uncertainty.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
AptarGroup specializes in designing and manufacturing packaging and dispensing systems, serving industries including pharmaceuticals, beauty, food, and beverages. Its core products include nasal sprays, injectable drug delivery components, fragrance and cosmetics pumps, and closures for food and drink containers. These solutions are used in everyday products such as asthma inhalers, allergy medications, perfumes, sauces, and drinks.
Source Fool.com
